MATTHEW MACALUSO: Open Payments
NPI 1417144023 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,166 in 18 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $8,215 · 2025 $9,166
Consulting: $7,125Travel & lodging: $1,469Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $9,145 |
| Abbott Laboratories | 1 | $21 |
Products named: CAPLYTA, INFINITY.
Industry payments across AL — which companies pay providers there.
